NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
CytRx Corp. (LSE: 0I5R)
0I5R Technical Analysis
5
As on 20th Sep 2022 0I5R STOCK Price closed @ 0.13 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.08 & Strong Sell for SHORT-TERM with Stoploss of 0.34 we also expect STOCK to react on Following IMPORTANT LEVELS. |
0I5RSTOCK Price
Open | 0.13 | Change | Price | % |
High | 0.13 | 1 Day | 0.03 | 30.00 |
Low | 0.13 | 1 Week | 0.02 | 18.18 |
Close | 0.13 | 1 Month | -0.36 | -73.47 |
Volume | 10000 | 1 Year | -0.61 | -82.43 |
52 Week High 0.76 | 52 Week Low 0.08 |
LSE UK Most Active Stocks
NTOG | 0.02 | -50.00% |
TRP | 0.03 | 0.00% |
VELA | 0.01 | % |
MSMN | 0.04 | 0.00% |
UKOG | 0.02 | 0.00% |
RRR | 0.04 | 0.00% |
DKE | 0.15 | 0.00% |
NNN | 0.09 | 50.00% |
DMTR | 0.03 | 0.00% |
BOIL | 0.08 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
0I5R Daily Charts |
0I5R Intraday Charts |
Whats New @ Bazaartrend |
0I5R Free Analysis |
|
0I5R Important Levels Intraday
RESISTANCE | 0.13 |
RESISTANCE | 0.13 |
RESISTANCE | 0.13 |
RESISTANCE | 0.13 |
RESISTANCE | 0.13 |
RESISTANCE | 0.13 |
RESISTANCE | 0.13 |
RESISTANCE | 0.13 |
0I5R Forecast November 2024
4th UP Forecast | 1.27 |
3rd UP Forecast | 0.9 |
2nd UP Forecast | 0.68 |
1st UP Forecast | 0.45 |
1st DOWN Forecast | -0.19 |
2nd DOWN Forecast | -0.42 |
3rd DOWN Forecast | -0.64 |
4th DOWN Forecast | -1.01 |
0I5R Weekly Forecast
4th UP Forecast | 0.59 |
3rd UP Forecast | 0.44 |
2nd UP Forecast | 0.35 |
1st UP Forecast | 0.26 |
1st DOWN Forecast | 0.00 |
2nd DOWN Forecast | -0.09 |
3rd DOWN Forecast | -0.18 |
4th DOWN Forecast | -0.33 |
0I5R Forecast2024
4th UP Forecast | 1.44 |
3rd UP Forecast | 1.02 |
2nd UP Forecast | 0.76 |
1st UP Forecast | 0.5 |
1st DOWN Forecast | -0.24 |
2nd DOWN Forecast | -0.5 |
3rd DOWN Forecast | -0.76 |
4th DOWN Forecast | -1.18 |
CytRx Corp. ( LSE UK Symbol : 0I5R )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
0I5R Other Details
Segment | EQ | |
Market Capital | 40824696.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
0I5R Address
0I5R Latest News
0I5R Business Profile
CytRx Corporation, a biopharmaceutical research and development company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8, LADR-9, and LADR-10; and Aldoxorubicin, a conjugate of prescribed cytotoxin agent doxorubicin that binds to circulating albumin in the bloodstream and to concentrate the drug at the site of the tumor. It also provides ACDx, an albumin companion diagnostic product to identify patients with cancer who are most likely to benefit from treatment with these drug candidates. CytRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California. Address: 11726 San Vicente Boulevard, Los Angeles, CA, United States, 90049
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service